Valuation (90%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.87 | N/A |
| PEG Ratio (TTM) | 0.73 | N/A |
| P/S Ratio (TTM) | 1.72 | N/A |
| P/B Ratio (TTM) | 1.13 | N/A |
| P/FCF Ratio (TTM) | 7.37 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.26 | N/A |
| Price to 5YR AVG FCF Ratio | 12.56 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.63% | N/A |
| ROE (TTM) | 8.56% | N/A |
| Net Profit Margin (TTM) | 12.60% | N/A |
| ROIC 5YR AVG | -5.67% | N/A |
Growth (38%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 38.39% | 3.20% | -2.61% |
| Revenue | 11.74% | 0.14% | -0.05% |
| Net Income | 31.62% | 1.51% | -4.48% |
| Cash Flow | 557.49% | -124.50% | -37.91% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 15.96 | N/A |
| Quick Ratio (TTM) | 15.96 | N/A |
| D/E Ratio (TTM) | 1.20 | N/A |
| Interest Coverage (TTM) | 0.31 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 0.87 | N/A |
| LTL to 5YR AVG FCF | 7.76 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.68% | N/A |